Copyright: ©Author(s) 2026.
World J Gastrointest Endosc. Oct 16, 2026; 18(10): 123858
Published online Oct 16, 2026. doi: 10.4253/wjge.123858
Published online Oct 16, 2026. doi: 10.4253/wjge.123858
Table 4 Pivotal medical therapy trials in Crohn’s disease strictures
| Trial | Design | n | Intervention | Primary success | Long-term |
| CREOLE (2018) | Prospective cohort | 97 | ADA | 64% at week 24 | 29% prolonged success at 4 years; 51% surgery-free |
| STRIDENT (2021) | RCT (intensive vs standard) | 77 | Intensive ADA + thiopurine | Symptom improvement 79% (vs 64%) at 12 months | < 33% surgery at 4.5 years |
| Post-hoc biologics | Pooled | > 500 | Anti-TNF, UST, VDZ | > 60% endoscopic response at 1 year | Reduced surgery |
- Citation: Mundhra SK, Singh AK, Kochhar R, Manrai M. Endoscopic management of intestinal strictures in Crohn’s disease: Current status and future perspectives. World J Gastrointest Endosc 2026; 18(10): 123858
- URL: https://www.wjgnet.com/1948-5190/full/v18/i10/123858.htm
- DOI: https://dx.doi.org/10.4253/wjge.123858